Anna Chan Kwong, Ph.D.

Director, MIDD Consultant

Portrait-of-Anna-Chan-Kwong-Pharmetheus

Bio

  • Joined Pharmetheus in 2021, actively working in client projects
  • Expertise includes pharmacometrics and pediatrics in therapeutic areas such as infectious diseases and immunology
  • M.Sc. in Biostatistics (2016) from Aix-Marseille University, France, PharmD and Ph.D. in Pharmacometrics (2021) from Montpellier and Aix-Marseille Universities, France
LinkedInGoogle Scholar

Pharmetheus affiliated publications

A mechanism-based parsimonious CAR-T cell population PK model and its validation via extension to a population PK-tumor size dynamics model: case study with axicabtagene ciloleucel and brexucabtagene autoleucelFood effect prediction of high permeability/low solubility, formulated as an amorphous solid dispersion (ASD) using an open systems pharmacology (OSP) PBBM approach